<!DOCTYPE html>

<html lang="fa">
<meta content="text/html;charset=utf-8" http-equiv="content-type"/>
<head><title>Clinical manifestations and diagnosis of mitral annular calcification</title><link href="/z/d/css/bootstrap.min.css" rel="stylesheet"/><link href="/z/d/css/icofont.min.css" rel="stylesheet"/><link href="/z/d/css/classy-nav.min.css" rel="stylesheet"/><link href="/z/d/css/animate.css" rel="stylesheet"/><link href="/z/d/css/owl.carousel.css" rel="stylesheet"/><link href="/z/d/css/magnific-popup.css" rel="stylesheet"/><link href="/z/d/css/owl.theme.default.min.css" rel="stylesheet"/><link href="/z/d/css/style.css" rel="stylesheet"/><link href="/z/d/css/rtl_edited.css" rel="stylesheet"/><link href="/z/d/css/responsive.css" rel="stylesheet"/><link href="https:///uptodate_assets/main.css" rel="stylesheet"/>
<style>

#myUL {
  list-style-type: none;
  padding: 0;
  margin: 0;
}

#myUL li a {
  border: 1px solid #ddd;
  margin-top: -1px; /* Prevent double borders */
  background-color: #f6f6f6;
  padding: 12px;
  text-decoration: none;
  font-size: 16px;
  color: black;
  display: block
}

#myUL li a:hover:not(.header) {
  background-color: #eee;
}

#searchResult {

  list-style-type: none;
  padding: 0;
  padding-right: 20px;
}

#searchResult li a {
  border: .5px solid #ddd;
  margin-top: -1px; /* Prevent double borders */
  background-color: #79bc21;
  padding: 7px;
  text-decoration: none;
  font-size: 14px;
  color: white;
  display: block
}

#searchResult li a:hover:not(.header) {
  background-color: #222;
}


#txtHint   {
  position: absolute;
  text-shadow: none;
  width: 100%;
  margin-top: -15px;
  padding-right: 10px;

  filter: alpha(opacity=95);
  -moz-opacity: 0.95;
  opacity: 1;
  z-index: 200;
}
.countBubl {
  background:#eb0029;
  color:#fff;
  padding:5px;
  margin-top: 50%;

}
.uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > span:nth-child(1) > img:nth-child(2) {
 width: 55%;
 padding-left: 20px;
}
.uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > span:nth-child(1) > img:nth-child(3) {
 width: 20%;
}
 #Uptodate_image {
      width: 50%;
  }#uptodate-area {
      /*z-index: 99;*/
  }
#uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > div:nth-child(2) {
 margin-left: 10px;
 margin-bottom: 6%;
}
@media (max-width: @screen-xs) {
    .countBubl {
        font-size: 4px ;
    }
    #uptodate_version {
        font-size: 4px ;
    }
}

@media (max-width: @screen-sm) {
    .countBubl {
        font-size: 14px ;
    }
}
@media  all and(max-width: 820) {
    #Uptodate_image {
        width: 80% ;
    }#uptodate-area {
        z-index: 99;
    }
}@media  all and (min-width: 820) and(max-width: 88820){
    #Uptodate_image {
        width: 100% !important;
    }
    .countBubl {
        font-size: 4px ;
    }
}
div.col-md-3:nth-child(3) {
 margin-top: 6%;
}

div.col-md-3:nth-child(3) > img:nth-child(1) {
 width: 100%;
 margin-left: 11px;
}

</style>
<style media="screen" type="text/css">
  .goback {
    width: 200px;
    height: 40px;
    line-height: 40px;
    position: fixed;
    display: none;
    font-size: 15px;
    background: #71c0fa;
    z-index: 1000;
    text-align: center;
    color: #ffffff;
    -webkit-border-radius: 1px;
    -moz-border-radius: 1px;
    border-radius: 50px;
    bottom: 3.8%;
    right: 2%;
}
  .buyPackage {
  width: 100px;
  height: 100px;
  line-height: 40px;
  position: fixed;
  display: none;
  font-size: 10px;
  background: #fa759e;
  z-index: 1000;
  text-align: center;
  color: #ffffff;
  -webkit-border-radius: 1px;
  -moz-border-radius: 1px;
  border-radius: 10px;
  top: 150px;
  right: 2%;
  text-align: center;
}
.uptodate-area {
  /*background-image: url(../../assets/img/news-letter-bg.jpg);*/
  background-position: center center;
  background-size: cover;
  background-repeat: no-repeat;
    background-attachment: fixed;
  position: relative;
}
.uptodate-area::before {
  content: '';
  position: absolute;
  left: 0;
  padding-top: 100px;
  width: 100%;
}
#references{
  display: none;
}
</style>
<style>
section.sticky {
  position: sticky;
  top: 0;
  background-color: #fff !important;
  /*z-index: 100;*/
  /*padding-top: 80px;*/

}
.m4inb{
    border: solid !important;
  }

  .newsletter-area::before {
       background: unset !important;
  }
p {
    color: #555;
}
</style>
<meta content="" name="description"/>
<link href="/z/d/img/favicon.png" rel="icon" type="image/png">
</link></head>
<body>
<!-- Start Main Menu Area -->
<br/>
<br/>
<br/>
<br/>
<div class="container">
<div class="row">
</div>
</div>
<section class="teacher-area ptb-10">
<div class="container">
</div>
<section class="course-details-area ptb-60">
<div class="container">
<div class="uptodate2" style="padding:50px 0px 50px 0px;direction: ltr;text-align: left;">
<h1 style="text-align:center">Clinical manifestations and diagnosis of mitral annular calcification</h1>
<div class="utdArticleSection utdStyle" id="topicContent"><div id="topicTitle">Clinical manifestations and diagnosis of mitral annular calcification</div> <div class="authorSectionElem"><div class="authorsElementsLeft"><dl id="topicContributors"><dt><span> </span>Author:</dt><dd><a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">Rosario V Freeman, MD, MS</a></dd><dt><span> </span>Section Editor:</dt><dd><a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">Catherine M Otto, MD</a></dd><dt><span> </span>Deputy Editor:</dt><dd><a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">Susan B Yeon, MD, JD</a></dd></dl></div><div class="authorsElementsRight"><div id="literatureReviewDate"><div class="litReviewSingleLine"><bdi><span class="emphasis">Literature review current through:</span> Jan 2024.</bdi></div><div class="litReviewSingleLine"><bdi><span class="emphasis">This topic last updated:</span> Jun 14, 2022.</bdi></div></div></div></div><div id="topicWhatsNewContainer"></div><div id="topicText"><p class="headingAnchor" id="H1"><span class="h1">INTRODUCTION</span><span class="headingEndMark"> — </span>Mitral annular calcification (MAC) is a chronic, progressive process involving the fibrous annulus of the mitral valve. It is most commonly asymptomatic and identified incidentally during cardiac imaging studies. MAC tends to be more prominent with aging, although other underlying processes, such as atherosclerosis, altered mineral metabolism, or increased mechanical stress, promote development of MAC. In advanced cases, MAC may be significant, causing obstruction of left ventricular (LV) inflow and symptomatic mitral stenosis. Cohort studies have demonstrated an association of MAC with atherosclerotic disease and adverse cardiovascular events, including stroke and increased mortality. Additionally, there is an association of MAC with arrhythmia, including atrial fibrillation (AF) and conduction system disease.</p><p>The clinical manifestations (including associated conditions) and diagnosis of MAC are discussed here. Management and prognosis in patients with MAC is discussed separately. (See  <a class="medical medical_review" href="/z/d/html/116169.html" rel="external">"Management and prognosis of mitral annular calcification"</a>.)</p><p class="headingAnchor" id="H2"><span class="h1">ANATOMY AND PATHOLOGY</span><span class="headingEndMark"> — </span>The mitral valve (MV) annulus has a complex three-dimensional shape analogous to a saddle with the relative nadirs of the annulus located medially and laterally. At the base of the LV, the annulus is composed of a C-shaped segment of fibrous skeleton. The MV leaflets are suspended from the mitral annulus, which provides structural support to the valve apparatus along the medial, posterior, and lateral aspects of the valve. Anteriorly, the midsection of the anterior mitral leaflet is in fibrous continuity with the posterior aortic root via the intervalvular fibrosa, without intervening annular tissue. In systole, normal mitral annular contraction is along the anteroposterior plane, resulting in folding along the mediolateral plane with a reduction in annular cross-sectional area, facilitating leaflet coaptation [<a href="#rid1">1,2</a>]. Three-dimensional echocardiography studies in patients with MAC have shown a relative loss of annular systolic motion, resulting in a larger, flatter annulus in systole [<a href="#rid3">3</a>].</p><p class="headingAnchor" id="H4"><span class="h2">Mitral annular calcification</span><span class="headingEndMark"> — </span>MAC is characterized by progressive calcium deposition along and beneath the MV annulus [<a href="#rid4">4</a>]. MAC generally follows the C-shaped fibrous skeleton of the posterior mitral annulus, with relative sparing of the base of the anterior mitral leaflet. Sparing of involvement of the mitral leaflet commissures and anterior annulus distinguishes MAC from rheumatic mitral disease. MAC is readily seen by echocardiography, appearing as a bright echodense region adjacent to the posterior atrioventricular (AV) groove  (<a class="graphic graphic_diagnosticimage graphicRef70235" href="/z/d/graphic/70235.html" rel="external">image 1A</a> and <a class="graphic graphic_diagnosticimage graphicRef80124" href="/z/d/graphic/80124.html" rel="external">image 1B</a>). Echocardiographic features of MAC are described below. (See <a class="local">'Identification of mitral annular calcification'</a> below.)</p><p>MAC is differentiated from other causes of calcific or degenerative MV disease, such as radiation valve disease. Mediastinal radiation therapy is a component of treatment for several malignancies, such as breast cancer and Hodgkin lymphoma. Patients who develop radiation-associated valve disease develop heavy calcification and fibrosis of left-sided cardiac structures, typically presenting after a lengthy latency period (10 to 20 years) following exposure. Severity of valve involvement is associated with radiation dose [<a href="#rid5">5</a>]. In contrast to MAC, which tends to involve the posterior mitral annulus, radiation valve disease is more likely to involve the aortic and MV and surrounding structures such as the aorto-mitral curtain, anterior MV annulus, and subvalvular apparatus. (See  <a class="medical medical_review" href="/z/d/html/7062.html" rel="external">"Cardiotoxicity of radiation therapy for breast cancer and other malignancies"</a>.)</p><p class="headingAnchor" id="H5"><span class="h2">Caseous calcification</span><span class="headingEndMark"> — </span>Caseous calcification of the mitral annulus is a rare (less than 1 percent) variant of MAC that appears as a smooth, round periannular mass [<a href="#rid6">6-8</a>]. Echocardiographic features are described below. (See <a class="local">'Caseous calcification'</a> below.)</p><p class="headingAnchor" id="H2473390124"><span class="h1">PATHOPHYSIOLOGY</span><span class="headingEndMark"> — </span>Data on the pathophysiology of MAC are limited. Initially thought to be a passive, degenerative process, MAC is now understood to be a more active process, akin to atherosclerosis and calcific aortic valve disease [<a href="#rid9">9</a>]. There is a strong association between atherosclerotic risk factors and valve calcification [<a href="#rid10">10,11</a>]. (See <a class="local">'Clinical manifestations'</a> below.)</p><p>MAC is thought to be initiated by endothelial disruption at foci of increased mechanical stress at the junction between the mitral valve (MV) annulus and ventricular myocardium. Focal accumulation of oxidized lipids serves as a nidus for chronic inflammatory cell infiltrates including T lymphocytes and macrophages, as well as activated mast cells that promote extracellular matrix remodeling [<a href="#rid12">12,13</a>]. Focal calcific deposits in regions of microinjury and lipoprotein accumulation may then coalesce over time into the dense, fibrotic, rigid band macroscopically evident as MAC. Conditions that increase mitral annular stress, such as higher LV systolic pressure (aortic stenosis or systemic hypertension) or higher leaflet tension (MV prolapse), are associated with MAC [<a href="#rid14">14,15</a>].</p><p>MAC may reflect systemic disorders of tissue mineralization. Among patients with end-stage renal disease, MAC was associated with an elevated calcium-phosphate product [<a href="#rid16">16,17</a>]. Increased serum phosphate has also been associated with aortic valve calcification, aortic annular calcification, and MAC [<a href="#rid18">18</a>].</p><p>MAC has been associated with systemic markers of inflammation [<a href="#rid19">19</a>]. In a report from the Cardiovascular Health Study, of 5888 participants, 3585 participants had inflammatory, lipid, and mineral biomarker data available, measured within five years of echocardiography. Fibroblast growth factor (FGF-23) was positively associated with MAC with a relative risk (RR) of 1.040 (95% CI 1.004-1.078), and fetuin A, a multifunctional glycoprotein that inhibits dystrophic calcification, was negatively associated with an RR of 0.989 (95% CI 0.911-0.989) [<a href="#rid20">20</a>]. While other studies have similarly demonstrated the inverse association of MAC with serum fetuin A [<a href="#rid21">21,22</a>], the association between MAC and systemic inflammatory markers may reflect shared risk factors. In a report from the Framingham Heart Study, while valvular calcification was associated with elevated levels of inflammatory markers, the association was no longer significant after adjusting for other cardiovascular disease risk factors [<a href="#rid19">19</a>].</p><p>Other contributing factors for earlier development of MAC (in adolescence or young adulthood) include connective tissue abnormalities and genetic abnormalities of the fibrous skeleton, such as Marfan syndrome [<a href="#rid23">23,24</a>], and systemic disease associated with chronic inflammation, such as systemic lupus erythematosus [<a href="#rid25">25</a>]. In an investigation of the potential genetic contribution to valve calcification, genomewide associations with MAC (detected by computed tomography scanning) were identified among 3795 participants from the Cohorts for Heart and Aging Research in Genomic Epidemiology consortium. Two single nucleotide polymorphisms, rs17659543 and rs13415097, near <em>IL1F9</em>, a proinflammatory gene, reached significance (p&lt;1.5x10<sup>-8</sup>) for MAC, but the findings could not be reliably replicated in independent cohorts. Genomewide associations with aortic valve calcification in this study were stronger, with results replicated in independent cohorts [<a href="#rid26">26</a>].</p><p class="headingAnchor" id="H7"><span class="h1">PREVALENCE</span></p><p class="headingAnchor" id="H8"><span class="h2">General</span><span class="headingEndMark"> — </span>Given that calcification of the mitral annulus without significant mitral inflow obstruction is asymptomatic, overall prevalence of MAC in the general population is underestimated. Published studies of MAC demonstrate that prevalence and severity of MAC increases with age [<a href="#rid27">27-31</a>]. In cohorts with mean age in the range of 50 to 60 years, reported prevalence of MAC was 3 to 9 percent [<a href="#rid14">14,27,28,32,33</a>]. In the multiethnic Northern Manhattan study cohort of 1955 subjects (older mean age 68 years) without prior myocardial infarction or ischemic stroke, MAC was identified in 27 percent [<a href="#rid34">34</a>].<strong> </strong>In two population-based studies of older patients, mean ages of 70 and 76 years, respectively, the prevalence of MAC was 14 percent (by M-mode echocardiography) and 42 percent (by two-dimensional echocardiography) [<a href="#rid30">30,31</a>]. The EuroHeart Survey was a prospective study of 5000 patients with moderate to severe valvular heart disease that showed that among age groups 60 to 70 years, 70 to 80 years, and over 80 years, MAC accounted for 10, 30, and 60 percent of mitral stenosis (MS) cases, respectively [<a href="#rid35">35</a>].</p><p>There are conflicting data on whether the prevalence of MAC is higher in females than males, as observed in some populations such as the Framingham Heart Study and the Multi-Ethnic Study of Atherosclerosis (MESA) population [<a href="#rid29">29,31,33,34</a>], or is similar in females and males, as noted in the Atherosclerosis Risk in Communities study and the Cardiovascular Health Study [<a href="#rid14">14,28,30</a>].</p><p>A single center study of 1004 patients with severe MAC and mean diastolic gradient over 2 mmHg reported baseline characteristics of older age (mean 73 years) with female preponderance (73 percent) [<a href="#rid36">36</a>]. In a retrospective study on the natural history of severe calcific MS (mitral valve area &lt;1.5 cm<sup>2</sup>) which included 200 patients, patients with severe MS were older (mean age 78 years) with higher likelihood of female sex (82 percent). With regards to symptom status, only 120 (60 percent) were symptomatic at baseline, with 20 patients (10 percent) developing symptoms during the 2.8-year follow-up period [<a href="#rid37">37</a>].</p><p class="headingAnchor" id="H9"><span class="h2">Kidney disease</span><span class="headingEndMark"> — </span>In patients with altered mineral metabolism, MAC is more prominent with accelerated progression. In patients with end-stage kidney disease, prevalence of aortic valve and mitral annular calcification is reported in the range of 35 to 50 percent despite a relatively younger age range (mean age of 50 to 60 years old) [<a href="#rid16">16,17,38</a>]. MAC is more common among those dialyzed for a longer period of time [<a href="#rid16">16</a>] and is associated with coronary artery disease, atherosclerotic vascular disease, and mortality [<a href="#rid17">17,38</a>].</p><p>Among 3929 subjects (mean age 74±5 years, 60 percent women) in the Cardiovascular Health Study, moderate kidney disease (estimated glomerular filtration rate [eGFR] <em>&lt;</em>45 mL/min/1.73 m<sup>2</sup>) was significantly associated with MAC (odds ratio [OR] 1.54) but not with aortic annular calcification or aortic valve sclerosis. Cystatin C levels (another marker of renal insufficiency) were also associated with MAC (OR 1.12) [<a href="#rid39">39</a>].</p><p>In an analysis from the MESA study, of 6785 participants, MAC was present in 8 percent of participants with eGFR ≥60 mL/min/1.73 m<sup>2</sup> (mean age 62 years) but increased to 20 percent of participants with a lower eGFR &lt;60 mL/min/1.73 m<sup>2</sup> (mean age 70 years). In adjusted analyses, eGFR &lt;60 mL/min/1.73 m<sup>2</sup> was associated with MAC among subjects with diabetes but not among those without diabetes [<a href="#rid40">40</a>]. From the Framingham Heart Study, of 3047 participants, 284 participants (9.3 percent) had valve/annular calcification. Of these, 20 percent had chronic renal insufficiency compared with just 7 percent in those without valve calcification. After adjustment for atherosclerotic risk factors, those with chronic renal insufficiency had a 60 percent increased likelihood of MAC (OR 1.6, 95% CI 1.03-2.5) [<a href="#rid41">41</a>].</p><p class="headingAnchor" id="H14"><span class="h1">CLINICAL MANIFESTATIONS</span><span class="headingEndMark"> — </span>MAC is typically asymptomatic, identified as an incidental finding in patients undergoing diagnostic imaging such as chest radiography, chest computed tomography, fluoroscopy, or echocardiography [<a href="#rid42">42,43</a>]. MAC generally has little or no hemodynamic impact on LV inflow or mitral valve (MV) function. However, extensive calcification may cause functional mitral stenosis (MS), mitral regurgitation (MR), or both (mixed disease) [<a href="#rid44">44-46</a>].</p><p class="headingAnchor" id="H16"><span class="h2">Mitral stenosis</span><span class="headingEndMark"> — </span>In severe cases, MAC leads to calcific MS with hemodynamically significant obstruction of LV inflow at the mitral annular level, impairment of diastolic annular motion, and restriction of MV leaflet motion [<a href="#rid45">45</a>].</p><p class="headingAnchor" id="H17"><span class="h2">Mitral regurgitation</span><span class="headingEndMark"> — </span>MAC may lead to MR by preventing normal systolic annular contraction [<a href="#rid45">45</a>] and restricting leaflet mobility. In a review of 24,380 echocardiograms, MAC was present in 11.7 percent of patients with MR and in 4.3 percent without MR [<a href="#rid27">27</a>].</p><p class="headingAnchor" id="H3436770600"><span class="h1">ASSOCIATED CONDITIONS</span></p><p class="headingAnchor" id="H18"><span class="h2">Aortic valve disease</span><span class="headingEndMark"> — </span>Given the similarities in pathologic appearance and clinical associations between MAC and aortic sclerosis, it is not surprising that patients with MAC often have concurrent calcification of the aortic valve annulus, aortic valve leaflets, and aortic root [<a href="#rid47">47</a>]. MAC is a risk factor for hemodynamic progression of calcific aortic valve disease [<a href="#rid9">9</a>]. In patient cohorts from transcatheter aortic valve implantation (TAVI) studies in which cardiac computed tomography (CT) is obtained during the pre-TAVI procedure evaluation, MAC is highly prevalent. In a single-center cohort of 346 patients referred for TAVI and screened with cardiac CT, 174 (50 percent) had MAC [<a href="#rid48">48</a>]. Of these, significant inflow obstruction (moderate or greater severity stenosis) was present in 34 percent of patients. In a cohort of 761 patients referred for TAVI, 49.3 percent had coexistent MAC [<a href="#rid49">49</a>]. Moderate MAC was present in 72 patients (9.5 percent), and severe MAC was present in 72 patients (9.5 percent).</p><p class="headingAnchor" id="H19"><span class="h2">Diastolic dysfunction</span><span class="headingEndMark"> — </span>MAC is associated with reduced early- and late-diastolic annular velocities [<a href="#rid50">50</a>]. Reduction in mitral annular motion in patients with MAC may be due to diastolic dysfunction associated with LV hypertrophy, which is associated with MAC [<a href="#rid27">27</a>]. (See <a class="local">'Interference with evaluation of concurrent conditions'</a> below.)</p><p class="headingAnchor" id="H20"><span class="h2">Arrhythmias</span></p><p class="headingAnchor" id="H21"><span class="h3">Conduction system disease and bradyarrhythmias</span><span class="headingEndMark"> — </span>MAC is associated with a high prevalence of conduction system disease (including AV block, bundle branch block, and intraventricular conduction delay) [<a href="#rid44">44,51</a>]. MAC is also associated with an increased rate of symptomatic bradyarrhythmias (due to sinus arrest or conduction system disease) requiring permanent pacemaker implantation [<a href="#rid52">52</a>]. In a single-center study of patients referred for TAVI, of 761 patients referred for TAVI, severe MAC was an independent predictor of need for new permanent pacer placement following TAVI procedure (odds ratio 2.83, 95% CI 1.08-7.47). There were 70 patients (11.6 percent) who required new pacemaker placement post-TAVI among the 606 patients that did not have a pacemaker prior to TAVI [<a href="#rid49">49</a>]. (See  <a class="medical medical_review" href="/z/d/html/941.html" rel="external">"Permanent cardiac pacing: Overview of devices and indications"</a>.)</p><p>The association between MAC and conduction disease may be due to direct extension of calcific deposits to the region of the AV node and His bundle. In a small study, conduction abnormalities (AV block), bundle branch block, or intraventricular conduction delay were more common in patients with MAC near the conduction system (53 percent) than in those with MAC further from the conduction system (26 percent) [<a href="#rid53">53</a>]. However, prevalence of conduction disturbances remote from MAC (eg, sinoatrial dysfunction) suggests that diffuse degenerative conduction system disease is also present [<a href="#rid52">52</a>].</p><p class="headingAnchor" id="H22"><span class="h3">Atrial fibrillation</span><span class="headingEndMark"> — </span>There is an association between MAC and AF [<a href="#rid33">33,54,55</a>]. A report from the Framingham Heart Study with 16 years of follow-up of 1126 subjects found that MAC was an independent predictor of incident AF (adjusted hazard ratio 1.6, 95% CI 1.1-2.2) [<a href="#rid55">55</a>]. Among 6641 participants in the Multi-Ethnic Study of Atherosclerosis (MESA), there was a strong association between MAC and AF, with higher risk for development of AF in patients who had progression of MAC severity across several evaluations [<a href="#rid56">56,57</a>].</p><p class="headingAnchor" id="H23"><span class="h2">Atherosclerotic cardiovascular disease</span><span class="headingEndMark"> — </span>MAC is significantly associated with coronary artery disease as detected by radionuclide myocardial perfusion imaging [<a href="#rid58">58</a>], coronary CT [<a href="#rid32">32,59</a>], or invasive coronary angiography [<a href="#rid60">60-62</a>]. In a population of 2465 patients with mean age 69 years who underwent coronary angiography for suspected coronary artery disease, the presence of MAC was associated with increased prevalence of &gt;70 percent coronary artery stenosis (80 percent in those with MAC versus 69 percent in those without MAC) [<a href="#rid62">62</a>]. In addition, significant three vessel disease was more common in patients with severe MAC (47 percent) and in those with mild to moderate MAC (35 percent) than in those with no MAC (30 percent).</p><p>Similarly, in the MESA population of 6814 subjects undergoing coronary CT scans, coronary artery calcification was present in 3398 (50 percent of the study cohort). After taking into account demographics and other risk factors, the prevalence ratio of MAC in those with mild coronary artery calcification (1 to 99) was 2.13 (95% CI 1.69-2.69) but increased to 7.57 (95% CI 5.95-9.62) for coronary artery calcification &gt;400. This association weakened but persisted after adjustment for age, sex, and other traditional cardiovascular risk factors, suggesting that MAC presence is an indicator of atherosclerotic burden [<a href="#rid32">32</a>].</p><p>MAC is also associated with atherosclerosis of the aorta, independent of cardiovascular risk factors, including carotid artery disease [<a href="#rid14">14,63,64</a>].</p><p class="headingAnchor" id="H2790377254"><span class="h2">Endocarditis</span></p><p class="headingAnchor" id="H868650892"><span class="h3">MAC at or near nidus of infection</span><span class="headingEndMark"> — </span>Case reports and published series have described infective endocarditis involving the mitral valve (MV) in patients with MAC. Endocarditis lesions have included MV leaflet vegetations, paravalvular abscess, and, less commonly, vegetations adherent to MAC [<a href="#rid65">65</a>]. These observational studies suggest that MAC endocarditis is associated with greater comorbidity (eg, diabetes mellitus and cancer) and poor clinical outcome with high in-hospital mortality [<a href="#rid65">65</a>]. A single-center retrospective review of echocardiographic studies in 56 patients with native MV endocarditis identified <em>Staphylococcus aureus </em>as the culprit in 28 patients and streptococcal species in 17 patients. When <em>S. aureus</em> was the infecting organism, the vegetation was adherent to MAC in 57 percent of cases. By contrast, streptococcal infections more predominantly affected the valve leaflets, suggesting that MAC may act as a nidus for infection, particularly for <em>S. aureus</em> infections [<a href="#rid66">66</a>]. The presence of MAC may obscure echocardiographic detection of adjacent abscess cavities due to acoustic shadowing of the ultrasound beam distal to the calcium. (See <a class="local">'MAC may obscure an abscess'</a> below.)</p><p>Limited data suggest a poor prognosis among patients with MAC undergoing surgery for MV infective endocarditis. In one series of 24 patients with MAC and endocarditis (18 with acute and 6 with healed endocarditis) undergoing mitral surgery, in-hospital mortality was 29 percent, with all early deaths occurring in patients operated on during the acute infection event [<a href="#rid67">67</a>]. Frequent comorbidities (eg, chronic kidney disease, cancer, coronary disease) contribute to poor outcomes.</p><p class="headingAnchor" id="H2120868954"><span class="h3">MAC may obscure an abscess</span><span class="headingEndMark"> — </span>The presence of MAC can interfere with echocardiographic identification of abscesses in the region of the calcified posterior mitral annulus. In a transesophageal echocardiography (TEE) study of 115 patients with definite infective endocarditis who underwent cardiac surgery, 38 percent had an abscess detected at surgery [<a href="#rid68">68</a>]. TEE detected an abscess in 48 percent of those with an abscess. The majority (61 percent) of missed abscesses were localized to the posterior mitral annulus, which was frequently calcified.</p><p class="headingAnchor" id="H2616399242"><span class="h2">Tricuspid annular calcification</span><span class="headingEndMark"> — </span>Tricuspid annular calcification (TAC) is much less common than MAC and does not typically progress to hemodynamically significant obstruction of right ventricular inflow. TAC has been reported in patients with chronic kidney disease [<a href="#rid69">69</a>] and in patients with pulmonic stenosis. Like MAC, a variant of TAC with caseous calcification has been reported  (<a class="graphic graphic_diagnosticimage graphicRef86968" href="/z/d/graphic/86968.html" rel="external">image 2</a>) [<a href="#rid6">6</a>]. (See <a class="local">'Caseous calcification'</a> above.)</p><p class="headingAnchor" id="H3012008539"><span class="h1">DIAGNOSTIC EVALUATION</span><span class="headingEndMark"> — </span>The diagnostic evaluation includes identification and characterization of MAC and identification and characterization of mitral stenosis (MS) and mitral regurgitation (MR) and associated conditions.</p><p class="headingAnchor" id="H3345730163"><span class="h2">Approach to diagnosis</span><span class="headingEndMark"> — </span>Echocardiography is the primary imaging modality for identification and characterization of MAC and associated mitral valve (MV) disease. For patients with an indication for MV surgery, computed tomography (CT) is a complementary imaging modality for MAC [<a href="#rid70">70</a>]. If echocardiography and CT findings are indeterminate for caseous calcification, cardiac magnetic resonance (CMR) may be helpful. For symptomatic patients with severe MAC for whom the severity of MS is uncertain, cardiac catheterization with hemodynamic assessment can be helpful [<a href="#rid46">46</a>].</p><p class="headingAnchor" id="H3146074556"><span class="h2">Echocardiography</span><span class="headingEndMark"> — </span>Echocardiography enables identification of MAC, evaluation of MV anatomy and valve hemodynamics (including assessment for MR), evaluation of biventricular function, estimation of pulmonary pressures, and identification of concurrent valve and cardiac conditions. In a retrospective echocardiography study of 24,380 echocardiographic examinations, MAC was independently associated with the presence of LV hypertrophy, MR, tricuspid regurgitation, aortic stenosis, left atrial (LA) enlargement, and reversed early to late filling (E/A) ratio [<a href="#rid27">27</a>].</p><p class="headingAnchor" id="H2588569787"><span class="h3">Identification of mitral annular calcification</span><span class="headingEndMark"> — </span>MAC is visualized by echocardiography as an echodense, irregular shelf-like structure involving the MV annulus adjacent to the posterior AV groove with associated acoustic shadowing  (<a class="graphic graphic_diagnosticimage graphicRef70235 graphicRef80124" href="/z/d/graphic/70235.html" rel="external">image 1A-B</a>). MAC is most commonly an incidental finding on echocardiographic imaging and is characteristically identified on parasternal and apical views of the left heart with acoustic shadowing of structures distal to the calcification. Although MV leaflets and chordae tendineae are generally not involved, in more advanced cases, calcification may progressively accumulate in the subvalvular region beneath the posterior leaflet with encroachment onto the leaflet and into the myocardial wall.</p><p>Severity of MAC is typically reported qualitatively, with calcification of less than one-third of the annulus graded as "mild" and greater than two-thirds graded as "severe." The thickness of the calcific band may also be measured via M-mode imaging from the parasternal long-axis view. (See  <a class="medical medical_review" href="/z/d/html/116169.html" rel="external">"Management and prognosis of mitral annular calcification", section on 'Prognosis'</a>.)</p><p class="headingAnchor" id="H3029894424"><span class="h4">Caseous calcification</span><span class="headingEndMark"> — </span>As noted above, caseous calcification is a rare variant of MAC. On echocardiography, caseous calcification is less echodense than typical MAC, a central echolucent zone is present, and acoustic shadowing is absent. The caseous contents of the mass have a putty-like consistency with microscopic features consistent with liquefaction necrosis with amorphous eosinophilic acellular material surrounded by macrophages and lymphocytes and multiple small calcifications [<a href="#rid6">6</a>].</p><p>Limited longitudinal observations indicate that caseous calcification may be a dynamic condition. Caseous calcification may spontaneously resolve [<a href="#rid71">71</a>] or convert to typical MAC, and typical MAC may rarely convert to caseous calcification [<a href="#rid7">7</a>]. Caseous calcification should not be misdiagnosed as a myocardial abscess, tumor, or thrombus.</p><p class="headingAnchor" id="H1708760699"><span class="h3">Evaluation of mitral stenosis</span><span class="headingEndMark"> — </span>MAC rarely progresses to significant obstruction to LV inflow and calcific MS. When calcific MS is suspected, the MV gradient and the MV area (MVA) should be assessed. In early-stage MS due to rheumatic valve disease, leaflet pliability is relatively preserved with inflow obstruction at the leaflet tips due to commissural fusion, resulting in a funnel shaped valve. In contrast, obstruction of mitral inflow with calcific MS due to MAC is at the level of the mitral annulus, with relative sparing of the leaflet tips, resulting in more of a tunnel-shaped orifice. As a consequence, there is relatively more rapid equalization of the LA to LV pressure gradient for calcific MS relative to that seen in rheumatic MS.</p><p class="headingAnchor" id="H194662745"><span class="h3">Hemodynamic assessment for mitral stenosis</span><span class="headingEndMark"> — </span>Spectral Doppler interrogation of the MV from the apical views of the heart provides hemodynamic data on functional restriction of LV inflow  (<a class="graphic graphic_diagnosticimage graphicRef86969" href="/z/d/graphic/86969.html" rel="external">image 3</a>). The LA to LV diastolic mean pressure gradient is calculated from the transmitral continuous wave Doppler signal, utilizing the simplified Bernoulli equation [<a href="#rid72">72</a>]. Stenosis of the MV with inflow obstruction increases transvalvular flow. Other conditions that increase transvalvular flow, such as increased heart rate or significant MR, will also increase transmitral gradient. Therefore, in addition to severity of inflow obstruction, transmitral gradients depend on length of the diastolic filling period, cardiac output, severity of associated MR (transvalvular flow), and factors which affect hemodynamic load, such as LV diastolic filling pressure and chamber compliance. Severity of anatomic valve obstruction from MAC, as assessed by the transmitral gradient, should account for LV diastolic dysfunction with high LV filling pressures, decreased LA compliance, and MR (increasing the early diastolic gradient, the mitral "E" wave). Without accounting for hemodynamic loading conditions, the transmitral gradient alone would overestimate anatomic severity of stenosis attributed to MAC. While higher diastolic mean gradients (over 5 mmHg) may be seen in severe cases of inflow obstruction, diastolic mean gradient is highly variable, dependent on heart rate and transmitral flow. As such, the transmitral gradient is not primarily recommended as a formal diagnostic criterion for MS severity in the clinical practice guidelines for valvular heart disease, which instead rely on Doppler-derived measurements of pressure half-time (PHT) and measurement of MVA [<a href="#rid73">73</a>].</p><p>A single-center retrospective study of patients with calcific MV disease correlated a "projected" transmitral mean gradient to the MVA. This study utilized data from 3315 patients to derive a formula for the projected mean gradient, accounting for heart rate, sex, and stroke volume, and validated their formula on an additional 1658 patients. A projected mean gradient &gt;6 mmHg was highly specific for identifying severe stenosis [<a href="#rid74">74</a>].</p><p>Estimation of MVA in patients with MAC is challenging, and none of the methods validated for rheumatic MS have been validated for calcific MS patients. Planimetry by two- or three-dimensional imaging rarely is possible because the flow-limiting area is the irregularly shaped, nonplanar calcified annulus, rather than a simple elliptical diastolic orifice seen with rheumatic disease. Also, relatively poor image quality from heavy calcium in MAC hinders direct planimetry of the tunnel-like orifice. If there is no significant aortic or MV regurgitation or AF, MVA calculation by continuity equation (using the mitral and LV outflow velocity time integrals to calculate volume of flow across the MV relative to forward stroke volume) is an alternative to planimetry (particularly if image quality is suboptimal) [<a href="#rid46">46,75</a>]. However, this method is less accurate in the setting of concurrent aortic valve disease. The proximal isovelocity surface area (PISA) method is another option to calculate MVA but is technically challenging to apply in the setting of calcific MS, given difficulty in measuring leaflet angles due to the bulky annular calcification.</p><p>PHT is the duration of time for the peak diastolic pressure gradient to decrease by half, derived from the continuous wave Doppler transmitral signal. From this, MVA may be calculated from the empirically derived equation (MVA = 220/PHT). However, this method for estimating MVA is relatively limited in patients with tachycardia, increased LV filling pressure, or abnormal LA compliance, conditions which are frequently concomitantly present in patients with advanced MAC [<a href="#rid76">76</a>]. With calcific MS, the initial transmitral gradient is higher with a shorter duration for PHT; therefore, MVA calculation using PHT tends to overestimate MVA [<a href="#rid77">77,78</a>]. In a study comparing methods for estimating MVA in patients with calcific MS, the PHT method overestimated MVA compared with MVA calculated by the continuity equation, while MVA determined by three-dimensional echocardiography was comparable with the continuity equation calculation [<a href="#rid77">77</a>].</p><p>From a practical standpoint, because of the challenges in evaluating MS severity in calcific MS, many clinicians utilize the PHT approach coupled with Doppler measures of the mean transmitral gradient, taking into account the effect of hemodynamic loading conditions, heart rate, and transmitral flow on diastolic gradients. Additional clinical indicators of disease severity include secondary changes due to MV obstruction, such as pulmonary hypertension, LA enlargement, and bowing the atrial septum.</p><p class="headingAnchor" id="H3769638536"><span class="h3">Evaluation of mitral regurgitation</span><span class="headingEndMark"> — </span>Color Doppler imaging can aid in evaluating the mechanism and severity of concurrent MR, although transthoracic images of MR jets in the LA are frequently suboptimal due to acoustic shadowing  (<a class="graphic graphic_diagnosticimage graphicRef86970" href="/z/d/graphic/86970.html" rel="external">image 4</a>). The impact of such shadowing may be reduced by acquiring multiple views of the valve on transthoracic echocardiography, although in some cases TEE (in which the LA is closer to the transducer and therefore not obscured by MAC) may be helpful to better visualize the extent of regurgitation. (See  <a class="medical medical_review" href="/z/d/html/5334.html" rel="external">"Echocardiographic evaluation of the mitral valve"</a> and  <a class="medical medical_review" href="/z/d/html/5329.html" rel="external">"Transesophageal echocardiography in the evaluation of mitral valve disease"</a>.)</p><p class="headingAnchor" id="H847218277"><span class="h2">Interference with evaluation of concurrent conditions</span><span class="headingEndMark"> — </span>MAC can interfere with echocardiographic evaluation of MR (see <a class="local">'Evaluation of mitral regurgitation'</a> above), detection of MV abscess (see <a class="local">'MAC may obscure an abscess'</a> above), interpretation of tissue Doppler velocities, and evaluation of other adjacent structures. (See <a class="local">'Evaluation of mitral regurgitation'</a> above and <a class="local">'MAC may obscure an abscess'</a> above.)</p><p>The presence of MAC impairs the accuracy of the early mitral inflow velocity to mitral annular early diastolic velocity (E/e') ratio estimation of pulmonary capillary wedge pressure. The mitral annular early diastolic velocity (e') is usually reduced in patients with significant MAC [<a href="#rid50">50</a>]. In addition, the early mitral inflow velocity (E) may be increased in the setting of significant MR, increased mitral inflow gradient, and decreased ventricular compliance. Therefore, the E/e' ratio is not accurate as an index of filling pressures in patients with heavy MAC [<a href="#rid79">79</a>]. (See  <a class="medical medical_review" href="/z/d/html/5304.html" rel="external">"Echocardiographic evaluation of left ventricular diastolic function in adults"</a>.)</p><p>In a study of 50 patients with MAC in which 26 patients had mild MAC and 24 patients had moderate or severe MAC, there was weak correlation (r = 0.42) between the E/e' ratio and LV filling pressure [<a href="#rid80">80</a>]. This study proposed a clinical algorithm utilizing mitral early to late filling (E/A) ratio and isovolumic relaxation time for prediction of higher LV filling pressure. A validation of the algorithm in a separate cohort yielded diagnostic accuracy of 94 percent. (See  <a class="medical medical_review" href="/z/d/html/5304.html" rel="external">"Echocardiographic evaluation of left ventricular diastolic function in adults"</a>.)</p><p class="headingAnchor" id="H618649188"><span class="h2">Cardiac catheterization</span><span class="headingEndMark"> — </span>For symptomatic patients with severe MAC for whom the severity of MS is uncertain, cardiac catheterization with hemodynamic assessment can be helpful [<a href="#rid46">46</a>]. The study should include simultaneous direct measurement of LA and LV pressures to measure the mean transmitral gradient as well as concomitant measurement of cardiac output with right heart catheterization to measure the MVA using the Gorlin formula, as discussed separately. (See  <a class="medical medical_review" href="/z/d/html/8127.html" rel="external">"Hemodynamics of valvular disorders as measured by cardiac catheterization", section on 'Mitral stenosis'</a> and  <a class="medical medical_review" href="/z/d/html/8173.html" rel="external">"Rheumatic mitral stenosis: Clinical manifestations and diagnosis", section on 'Cardiac catheterization'</a>.)</p><p class="headingAnchor" id="H1105303196"><span class="h2">Computed tomography</span><span class="headingEndMark"> — </span>CT is an effective, noninvasive diagnostic test for cardiac calcification (atherosclerotic disease, valve calcification, aortic atherosclerosis). High spatial resolution of cardiac CT allows for accurate identification of the severity and extent of calcification. Gating of the CT scan to the electrocardiogram decreases artifact due to cardiac motion, improving image quality. Although both contrast and noncontrast CT studies can assess the extent of mitral calcification, contrast is needed to evaluate cardiac structures, such as MV leaflet calcification, involvement of the subvalvular apparatus, or extension of calcification to the myocardium. Cardiac CT imaging also allows for anatomic assessment of other cardiac structures, including coronary arteries and the aorta, but does not allow for hemodynamic assessment of valve function [<a href="#rid46">46</a>].</p><p>CT is helpful for distinguishing caseous calcification from other types of cardiac mass. On CT, caseous calcification is identified as a non-contrast-enhancing, well-defined oval or crescent-shaped, hyperdense mass surrounded by dense calcification, usually located along the posterior mitral annulus [<a href="#rid8">8,46</a>].</p><p>Cardiac CT is increasingly utilized in preprocedure planning to evaluate mitral annular calcium burden and anatomy. For patients under evaluation for percutaneous transcatheter valve interventions, preprocedure CT may aid in assessment for potential LV outflow tract (LVOT) obstruction created by protrusion of the valve and displaced anterior MV leaflet into the LVOT. Risk of LVOT obstruction is higher in patients with a small LV, longer or redundant anterior MV leaflet, and small aortomitral angle.</p><p class="headingAnchor" id="H3873708583"><span class="h2">Cardiac magnetic resonance</span><span class="headingEndMark"> — </span>CMR is not generally used to detect MAC, as calcium is hypointense relative to myocardium [<a href="#rid43">43</a>], but CMR may be helpful in evaluating caseous calcification [<a href="#rid8">8,46</a>]. On CMR, caseous calcification appears as a well-defined mass with a hyperintense center and hypointense rim on T1-weighted fast spin-echo imaging or T1-weighted spoiled gradient-echo imaging [<a href="#rid8">8</a>]. On T2-weighted imaging, caseous calcification appears as a mass without central signal and with a high intensity ring [<a href="#rid8">8</a>].</p><p class="headingAnchor" id="H2682843371"><span class="h2">Differential diagnosis</span><span class="headingEndMark"> — </span>While MAC is generally recognized by its characteristic density, location, and shape on echocardiography and CT, unusual variants are sometimes confused with other lesions. Characteristic features of MAC (including caseous calcification) on echocardiography, CT, and CMR as described above distinguish MAC from myocardial abscess, tumor, or thrombus or lipomatosis of the AV groove. (See <a class="local">'Caseous calcification'</a> above and  <a class="medical medical_review" href="/z/d/html/4881.html" rel="external">"Cardiac tumors"</a>.)</p><p class="headingAnchor" id="H2421514381"><span class="h1">SOCIETY GUIDELINE LINKS</span><span class="headingEndMark"> — </span>Links to society and government-sponsored guidelines from selected countries and regions around the world are provided separately. (See  <a class="medical medical_society_guidelines" href="/z/d/html/115482.html" rel="external">"Society guideline links: Cardiac valve disease"</a>.)</p><p class="headingAnchor" id="H39"><span class="h1">SUMMARY AND RECOMMENDATIONS</span></p><p class="bulletIndent1"><span class="glyph">●</span>Mitral annular calcification (MAC) may be caused by a process similar to atherosclerosis and calcific aortic valve disease. There is a strong association between MAC and atherosclerotic risk factors and valve calcification. (See <a class="local">'Pathophysiology'</a> above.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>The prevalence and severity of MAC increase with age. MAC is particularly common in patients with end-stage kidney disease. (See <a class="local">'Prevalence'</a> above.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>MAC is generally an incidental finding associated with aging, although it is occasionally prominent enough to cause mitral stenosis (MS), mitral regurgitation (MR), or both (mixed disease). (See <a class="local">'Clinical manifestations'</a> above.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>MAC is associated with a number of conditions including calcific aortic valve disease, diastolic dysfunction, conduction system disease, atrial fibrillation (AF), and atherosclerotic cardiovascular disease. (See <a class="local">'Associated conditions'</a> above.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Endocarditis lesions identified in patients with MAC have vegetations on the mitral valve (MV) leaflets and, less commonly, vegetations adherent to MAC, as well as paravalvular abscesses in the region of MAC. The presence of MAC can interfere with identification of an abscess near the posterior mitral annulus. (See <a class="local">'Endocarditis'</a> above.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Echocardiography is the primary imaging modality for identification and characterization of MAC and associated MV disease. For patients undergoing evaluation for MV replacement, computed tomography is a complementary imaging modality that allows for assessment of the extent and location of annular calcium. (See <a class="local">'Diagnostic evaluation'</a> above.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>In patients with MAC, the initial transmitral gradient may be increased due to other comorbid conditions, such as high LV filling pressures, decreased left atrial compliance, or high transvalvular flow from concomitant MR (rather than valve obstruction), potentially leading to overestimation of stenosis severity.</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>MV area (MVA) estimation in patients with MAC is challenging; pressure half-time calculation of MVA in patients with MAC tends to overestimate valve area and planimetry of orifice area is rarely possible. From a practical standpoint, because of the challenges in evaluating MS severity in calcific MS, many clinicians utilize the pressure half-time (PHT) approach coupled with Doppler measures of the mean transmitral gradient, taking into account the effect of hemodynamic loading conditions, heart rate, and transmitral flow on diastolic gradients. (See <a class="local">'Evaluation of mitral stenosis'</a> above.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>The presence of MAC can obscure echocardiographic quantification of MR, identification of MV abscess, and estimation of pulmonary capillary wedge pressure. (See <a class="local">'Interference with evaluation of concurrent conditions'</a> above.)</p></div><div class="headingAnchor" id="references"><ol id="reference"><li><a class="nounderline abstract_t">Silbiger JJ, Bazaz R. Contemporary insights into the functional anatomy of the mitral valve. Am Heart J 2009; 158:887.</a></li><li><a class="nounderline abstract_t">Silbiger JJ. Anatomy, mechanics, and pathophysiology of the mitral annulus. Am Heart J 2012; 164:163.</a></li><li><a class="nounderline abstract_t">Pressman GS, Movva R, Topilsky Y, et al. Mitral Annular Dynamics in Mitral Annular Calcification: A Three-Dimensional Imaging Study. J Am Soc Echocardiogr 2015; 28:786.</a></li><li><a class="nounderline abstract_t">Fulkerson PK, Beaver BM, Auseon JC, Graber HL. Calcification of the mitral annulus: etiology, clinical associations, complications and therapy. Am J Med 1979; 66:967.</a></li><li><a class="nounderline abstract_t">Cutter DJ, Schaapveld M, Darby SC, et al. Risk of valvular heart disease after treatment for Hodgkin lymphoma. J Natl Cancer Inst 2015; 107.</a></li><li><a class="nounderline abstract_t">Harpaz D, Auerbach I, Vered Z, et al. Caseous calcification of the mitral annulus: a neglected, unrecognized diagnosis. J Am Soc Echocardiogr 2001; 14:825.</a></li><li><a class="nounderline abstract_t">Deluca G, Correale M, Ieva R, et al. The incidence and clinical course of caseous calcification of the mitral annulus: a prospective echocardiographic study. J Am Soc Echocardiogr 2008; 21:828.</a></li><li><a class="nounderline abstract_t">Elgendy IY, Conti CR. Caseous calcification of the mitral annulus: a review. Clin Cardiol 2013; 36:E27.</a></li><li><a class="nounderline abstract_t">Freeman RV, Otto CM. Spectrum of calcific aortic valve disease: pathogenesis, disease progression, and treatment strategies. Circulation 2005; 111:3316.</a></li><li><a class="nounderline abstract_t">Roberts WC. The senile cardiac calcification syndrome. Am J Cardiol 1986; 58:572.</a></li><li><a class="nounderline abstract_t">Adler Y, Fink N, Spector D, et al. Mitral annulus calcification--a window to diffuse atherosclerosis of the vascular system. Atherosclerosis 2001; 155:1.</a></li><li><a class="nounderline abstract_t">Helske S, Syväranta S, Kupari M, et al. Possible role for mast cell-derived cathepsin G in the adverse remodelling of stenotic aortic valves. Eur Heart J 2006; 27:1495.</a></li><li><a class="nounderline abstract_t">Helske S, Kupari M, Lindstedt KA, Kovanen PT. Aortic valve stenosis: an active atheroinflammatory process. Curr Opin Lipidol 2007; 18:483.</a></li><li><a class="nounderline abstract_t">Allison MA, Cheung P, Criqui MH, et al. Mitral and aortic annular calcification are highly associated with systemic calcified atherosclerosis. Circulation 2006; 113:861.</a></li><li><a class="nounderline abstract_t">Elmariah S, Delaney JA, Bluemke DA, et al. Associations of LV hypertrophy with prevalent and incident valve calcification: Multi-Ethnic Study of Atherosclerosis. JACC Cardiovasc Imaging 2012; 5:781.</a></li><li><a class="nounderline abstract_t">Maher ER, Young G, Smyth-Walsh B, et al. Aortic and mitral valve calcification in patients with end-stage renal disease. Lancet 1987; 2:875.</a></li><li><a class="nounderline abstract_t">Sharma R, Pellerin D, Gaze DC, et al. Mitral annular calcification predicts mortality and coronary artery disease in end stage renal disease. Atherosclerosis 2007; 191:348.</a></li><li><a class="nounderline abstract_t">Linefsky JP, O'Brien KD, Katz R, et al. Association of serum phosphate levels with aortic valve sclerosis and annular calcification: the cardiovascular health study. J Am Coll Cardiol 2011; 58:291.</a></li><li><a class="nounderline abstract_t">Fox CS, Guo CY, Larson MG, et al. Relations of inflammation and novel risk factors to valvular calcification. Am J Cardiol 2006; 97:1502.</a></li><li><a class="nounderline abstract_t">Bortnick AE, Bartz TM, Ix JH, et al. Association of inflammatory, lipid and mineral markers with cardiac calcification in older adults. Heart 2016; 102:1826.</a></li><li><a class="nounderline abstract_t">Ix JH, Chertow GM, Shlipak MG, et al. Association of fetuin-A with mitral annular calcification and aortic stenosis among persons with coronary heart disease: data from the Heart and Soul Study. Circulation 2007; 115:2533.</a></li><li><a class="nounderline abstract_t">Wang AY, Woo J, Lam CW, et al. Associations of serum fetuin-A with malnutrition, inflammation, atherosclerosis and valvular calcification syndrome and outcome in peritoneal dialysis patients. Nephrol Dial Transplant 2005; 20:1676.</a></li><li><a class="nounderline abstract_t">Correia J, Rodrigues D, da Silva AM, et al. Massive calcification of the mitral valve annulus in an adolescent with Marfan syndrome. A case report. Rev Port Cardiol 2006; 25:921.</a></li><li><a class="nounderline abstract_t">Radke RM, Baumgartner H. Diagnosis and treatment of Marfan syndrome: an update. Heart 2014; 100:1382.</a></li><li><a class="nounderline abstract_t">Molad Y, Levin-Iaina N, Vaturi M, et al. Heart valve calcification in young patients with systemic lupus erythematosus: a window to premature atherosclerotic vascular morbidity and a risk factor for all-cause mortality. Atherosclerosis 2006; 185:406.</a></li><li><a class="nounderline abstract_t">Thanassoulis G, Campbell CY, Owens DS, et al. Genetic associations with valvular calcification and aortic stenosis. N Engl J Med 2013; 368:503.</a></li><li><a class="nounderline abstract_t">Movahed MR, Saito Y, Ahmadi-Kashani M, Ebrahimi R. Mitral annulus calcification is associated with valvular and cardiac structural abnormalities. Cardiovasc Ultrasound 2007; 5:14.</a></li><li><a class="nounderline abstract_t">Fox E, Harkins D, Taylor H, et al. Epidemiology of mitral annular calcification and its predictive value for coronary events in African Americans: the Jackson Cohort of the Atherosclerotic Risk in Communities Study. Am Heart J 2004; 148:979.</a></li><li><a class="nounderline abstract_t">Savage DD, Garrison RJ, Castelli WP, et al. Prevalence of submitral (anular) calcium and its correlates in a general population-based sample (the Framingham Study). Am J Cardiol 1983; 51:1375.</a></li><li><a class="nounderline abstract_t">Barasch E, Gottdiener JS, Larsen EK, et al. Clinical significance of calcification of the fibrous skeleton of the heart and aortosclerosis in community dwelling elderly. The Cardiovascular Health Study (CHS). Am Heart J 2006; 151:39.</a></li><li><a class="nounderline abstract_t">Fox CS, Vasan RS, Parise H, et al. Mitral annular calcification predicts cardiovascular morbidity and mortality: the Framingham Heart Study. Circulation 2003; 107:1492.</a></li><li><a class="nounderline abstract_t">Hamirani YS, Nasir K, Blumenthal RS, et al. Relation of mitral annular calcium and coronary calcium (from the Multi-Ethnic Study of Atherosclerosis [MESA]). Am J Cardiol 2011; 107:1291.</a></li><li><a class="nounderline abstract_t">Potpara TS, Vasiljevic ZM, Vujisic-Tesic BD, et al. Mitral annular calcification predicts cardiovascular morbidity and mortality in middle-aged patients with atrial fibrillation: the Belgrade Atrial Fibrillation Study. Chest 2011; 140:902.</a></li><li><a class="nounderline abstract_t">Kohsaka S, Jin Z, Rundek T, et al. Impact of mitral annular calcification on cardiovascular events in a multiethnic community: the Northern Manhattan Study. JACC Cardiovasc Imaging 2008; 1:617.</a></li><li><a class="nounderline abstract_t">Iung B, Baron G, Butchart EG, et al. A prospective survey of patients with valvular heart disease in Europe: The Euro Heart Survey on Valvular Heart Disease. Eur Heart J 2003; 24:1231.</a></li><li><a class="nounderline abstract_t">Pasca I, Dang P, Tyagi G, Pai RG. Survival in Patients with Degenerative Mitral Stenosis: Results from a Large Retrospective Cohort Study. J Am Soc Echocardiogr 2016; 29:461.</a></li><li><a class="nounderline abstract_t">Kato N, Padang R, Scott CG, et al. The Natural History of Severe Calcific Mitral Stenosis. J Am Coll Cardiol 2020; 75:3048.</a></li><li><a class="nounderline abstract_t">Varma R, Aronow WS, McClung JA, et al. Prevalence of valve calcium and association of valve calcium with coronary artery disease, atherosclerotic vascular disease, and all-cause mortality in 137 patients undergoing hemodialysis for chronic renal failure. Am J Cardiol 2005; 95:742.</a></li><li><a class="nounderline abstract_t">Asselbergs FW, Mozaffarian D, Katz R, et al. Association of renal function with cardiac calcifications in older adults: the cardiovascular health study. Nephrol Dial Transplant 2009; 24:834.</a></li><li><a class="nounderline abstract_t">Ix JH, Shlipak MG, Katz R, et al. Kidney function and aortic valve and mitral annular calcification in the Multi-Ethnic Study of Atherosclerosis (MESA). Am J Kidney Dis 2007; 50:412.</a></li><li><a class="nounderline abstract_t">Fox CS, Larson MG, Vasan RS, et al. Cross-sectional association of kidney function with valvular and annular calcification: the Framingham heart study. J Am Soc Nephrol 2006; 17:521.</a></li><li><a class="nounderline abstract_t">Di Bella G, Carerj S, Andò G, et al. Cardiac imaging in the evaluation of mitral annulus caseous calcification. Int J Cardiol 2006; 113:E30.</a></li><li><a class="nounderline abstract_t">Gulati A, Chan C, Duncan A, et al. Multimodality cardiac imaging in the evaluation of mitral annular caseous calcification. Circulation 2011; 123:e1.</a></li><li><a class="nounderline abstract_t">D'Cruz IA, Cohen HC, Prabhu R, et al. Clinical manifestations of mitral annulus calcification, with emphasis on its echocardiographic features. Am Heart J 1977; 94:367.</a></li><li><a class="nounderline abstract_t">Osterberger LE, Goldstein S, Khaja F, Lakier JB. Functional mitral stenosis in patients with massive mitral annular calcification. Circulation 1981; 64:472.</a></li><li><a class="nounderline abstract_t">Eleid MF, Foley TA, Said SM, et al. Severe Mitral Annular Calcification: Multimodality Imaging for Therapeutic Strategies and Interventions. JACC Cardiovasc Imaging 2016; 9:1318.</a></li><li><a class="nounderline abstract_t">Jassal DS, Tam JW, Bhagirath KM, et al. Association of mitral annular calcification and aortic valve morphology: a substudy of the aortic stenosis progression observation measuring effects of rosuvastatin (ASTRONOMER) study. Eur Heart J 2008; 29:1542.</a></li><li><a class="nounderline abstract_t">Mejean S, Bouvier E, Bataille V, et al. Mitral Annular Calcium and Mitral Stenosis Determined by Multidetector Computed Tomography in Patients Referred for Aortic Stenosis. Am J Cardiol 2016; 118:1251.</a></li><li><a class="nounderline abstract_t">Abramowitz Y, Kazuno Y, Chakravarty T, et al. Concomitant mitral annular calcification and severe aortic stenosis: prevalence, characteristics and outcome following transcatheter aortic valve replacement. Eur Heart J 2017; 38:1194.</a></li><li><a class="nounderline abstract_t">Soeki T, Fukuda N, Shinohara H, et al. Mitral inflow and mitral annular motion velocities in patients with mitral annular calcification: evaluation by pulsed Doppler echocardiography and pulsed Doppler tissue imaging. Eur J Echocardiogr 2002; 3:128.</a></li><li><a class="nounderline abstract_t">Mellino M, Salcedo EE, Lever HM, et al. Echographic-quantified severity of mitral anulus calcification: prognostic correlation to related hemodynamic, valvular, rhythm, and conduction abnormalities. Am Heart J 1982; 103:222.</a></li><li><a class="nounderline abstract_t">Nair CK, Sketch MH, Desai R, et al. High prevalence of symptomatic bradyarrhythmias due to atrioventricular node-fascicular and sinus node-atrial disease in patients with mitral anular calcification. Am Heart J 1982; 103:226.</a></li><li><a class="nounderline abstract_t">Takamoto T, Popp RL. Conduction disturbances related to the site and severity of mitral anular calcification: a 2-dimensional echocardiographic and electrocardiographic correlative study. Am J Cardiol 1983; 51:1644.</a></li><li><a class="nounderline abstract_t">Nair CK, Thomson W, Ryschon K, et al. Long-term follow-up of patients with echocardiographically detected mitral anular calcium and comparison with age- and sex-matched control subjects. Am J Cardiol 1989; 63:465.</a></li><li><a class="nounderline abstract_t">Fox CS, Parise H, Vasan RS, et al. Mitral annular calcification is a predictor for incident atrial fibrillation. Atherosclerosis 2004; 173:291.</a></li><li><a class="nounderline abstract_t">O'Neal WT, Efird JT, Nazarian S, et al. Mitral annular calcification and incident atrial fibrillation in the Multi-Ethnic Study of Atherosclerosis. Europace 2015; 17:358.</a></li><li><a class="nounderline abstract_t">O'Neal WT, Efird JT, Nazarian S, et al. Mitral annular calcification progression and the risk of atrial fibrillation: results from MESA. Eur Heart J Cardiovasc Imaging 2018; 19:279.</a></li><li><a class="nounderline abstract_t">Jeon DS, Atar S, Brasch AV, et al. Association of mitral annulus calcification, aortic valve sclerosis and aortic root calcification with abnormal myocardial perfusion single photon emission tomography in subjects age &lt; or =65 years old. J Am Coll Cardiol 2001; 38:1988.</a></li><li><a class="nounderline abstract_t">Tenenbaum A, Shemesh J, Fisman EZ, Motro M. Advanced mitral annular calcification is associated with severe coronary calcification on fast dual spiral computed tomography. Invest Radiol 2000; 35:193.</a></li><li><a class="nounderline abstract_t">Atar S, Jeon DS, Luo H, Siegel RJ. Mitral annular calcification: a marker of severe coronary artery disease in patients under 65 years old. Heart 2003; 89:161.</a></li><li><a class="nounderline abstract_t">Adler Y, Herz I, Vaturi M, et al. Mitral annular calcium detected by transthoracic echocardiography is a marker for high prevalence and severity of coronary artery disease in patients undergoing coronary angiography. Am J Cardiol 1998; 82:1183.</a></li><li><a class="nounderline abstract_t">Kannam H, Aronow WS, Chilappa K, et al. Comparison of prevalence of &gt;70% diameter narrowing of one or more major coronary arteries in patients with versus without mitral annular calcium and clinically suspected coronary artery disease. Am J Cardiol 2008; 101:467.</a></li><li><a class="nounderline abstract_t">Adler Y, Vaturi M, Fink N, et al. Association between mitral annulus calcification and aortic atheroma: a prospective transesophageal echocardiographic study. Atherosclerosis 2000; 152:451.</a></li><li><a class="nounderline abstract_t">Antonini-Canterin F, Capanna M, Manfroni A, et al. Association between mitral annular calcium and carotid artery stenosis and role of age and gender. Am J Cardiol 2001; 88:581.</a></li><li><a class="nounderline abstract_t">Eicher JC, De Nadai L, Soto FX, et al. Bacterial endocarditis complicating mitral annular calcification: a clinical and echocardiographic study. J Heart Valve Dis 2004; 13:217.</a></li><li><a class="nounderline abstract_t">Pressman GS, Rodriguez-Ziccardi M, Gartman CH, et al. Mitral Annular Calcification as a Possible Nidus for Endocarditis: A Descriptive Series with Bacteriological Differences Noted. J Am Soc Echocardiogr 2017; 30:572.</a></li><li><a class="nounderline abstract_t">Vistarini N, d'Alessandro C, Aubert S, et al. Surgery for infective endocarditis on mitral annulus calcification. J Heart Valve Dis 2007; 16:611.</a></li><li><a class="nounderline abstract_t">Hill EE, Herijgers P, Claus P, et al. Abscess in infective endocarditis: the value of transesophageal echocardiography and outcome: a 5-year study. Am Heart J 2007; 154:923.</a></li><li><a class="nounderline abstract_t">Bittrick J, D'Cruz IA, Wall BM, et al. Differences and similarities between patients with and without end-stage renal disease, with regard to location of intracardiac calcification. Echocardiography 2002; 19:1.</a></li><li><a class="nounderline abstract_t">Higgins J, Mayo J, Skarsgard P. Cardiac computed tomography facilitates operative planning in patients with mitral calcification. Ann Thorac Surg 2013; 95:e9.</a></li><li><a class="nounderline abstract_t">Gramenzi S, Mazzola AA, Tagliaferri B, et al. Caseous calcification of the mitral annulus: unusual case of spontaneous resolution. Echocardiography 2005; 22:510.</a></li><li><a class="nounderline abstract_t">Reddy YNV, Murgo JP, Nishimura RA. Complexity of Defining Severe "Stenosis" From Mitral Annular Calcification. Circulation 2019; 140:523.</a></li><li><a class="nounderline abstract_t">Otto CM, Nishimura RA, Bonow RO, et al. 2020 ACC/AHA Guideline for the Management of Patients With Valvular Heart Disease: A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines. Circulation 2021; 143:e72.</a></li><li><a class="nounderline abstract_t">Kato N, Pislaru SV, Padang R, et al. A Novel Assessment Using Projected Transmitral Gradient Improves Diagnostic Yield of Doppler Hemodynamics in Rheumatic and Calcific Mitral Stenosis. JACC Cardiovasc Imaging 2021; 14:559.</a></li><li><a class="nounderline abstract_t">Baumgartner H, Hung J, Bermejo J, et al. Echocardiographic assessment of valve stenosis: EAE/ASE recommendations for clinical practice. J Am Soc Echocardiogr 2009; 22:1.</a></li><li><a class="nounderline abstract_t">Jain S, Mankad SV. Echocardiographic assessment of mitral stenosis: echocardiographic features of rheumatic mitral stenosis. Cardiol Clin 2013; 31:177.</a></li><li><a class="nounderline abstract_t">Chu JW, Levine RA, Chua S, et al. Assessing mitral valve area and orifice geometry in calcific mitral stenosis: a new solution by real-time three-dimensional echocardiography. J Am Soc Echocardiogr 2008; 21:1006.</a></li><li><a class="nounderline abstract_t">Joint Task Force on the Management of Valvular Heart Disease of the European Society of Cardiology (ESC), European Association for Cardio-Thoracic Surgery (EACTS), Vahanian A, et al. Guidelines on the management of valvular heart disease (version 2012). Eur Heart J 2012; 33:2451.</a></li><li><a class="nounderline abstract_t">Nagueh SF, Smiseth OA, Appleton CP, et al. Recommendations for the Evaluation of Left Ventricular Diastolic Function by Echocardiography: An Update from the American Society of Echocardiography and the European Association of Cardiovascular Imaging. J Am Soc Echocardiogr 2016; 29:277.</a></li><li><a class="nounderline abstract_t">Abudiab MM, Chebrolu LH, Schutt RC, et al. Doppler Echocardiography for the Estimation of LV Filling Pressure in Patients With Mitral Annular Calcification. JACC Cardiovasc Imaging 2017; 10:1411.</a></li></ol></div><div id="topicVersionRevision">Topic 8122 Version 17.0</div></div>
<div class="row">
<div class="col-12">
<h4 style="text-align: center;padding: 20px;color: cadetblue;">References</h4>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/19958853" id="rid0" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>1 : Contemporary insights into the functional anatomy of the mitral valve.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/22877801" id="rid1" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>2 : Anatomy, mechanics, and pathophysiology of the mitral annulus.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/25835341" id="rid2" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>3 : Mitral Annular Dynamics in Mitral Annular Calcification: A Three-Dimensional Imaging Study.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/156499" id="rid3" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>4 : Calcification of the mitral annulus: etiology, clinical associations, complications and therapy.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/25713164" id="rid4" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>5 : Risk of valvular heart disease after treatment for Hodgkin lymphoma.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/11490332" id="rid5" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>6 : Caseous calcification of the mitral annulus: a neglected, unrecognized diagnosis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/18222637" id="rid6" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>7 : The incidence and clinical course of caseous calcification of the mitral annulus: a prospective echocardiographic study.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/24038099" id="rid7" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>8 : Caseous calcification of the mitral annulus: a review.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/15967862" id="rid8" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>9 : Spectrum of calcific aortic valve disease: pathogenesis, disease progression, and treatment strategies.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/3751927" id="rid9" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>10 : The senile cardiac calcification syndrome.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/11223420" id="rid10" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>11 : Mitral annulus calcification--a window to diffuse atherosclerosis of the vascular system.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/16401677" id="rid11" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>12 : Possible role for mast cell-derived cathepsin G in the adverse remodelling of stenotic aortic valves.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/17885417" id="rid12" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>13 : Aortic valve stenosis: an active atheroinflammatory process.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/16461818" id="rid13" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>14 : Mitral and aortic annular calcification are highly associated with systemic calcified atherosclerosis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/22897991" id="rid14" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>15 : Associations of LV hypertrophy with prevalent and incident valve calcification: Multi-Ethnic Study of Atherosclerosis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/2889080" id="rid15" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>16 : Aortic and mitral valve calcification in patients with end-stage renal disease.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/16647710" id="rid16" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>17 : Mitral annular calcification predicts mortality and coronary artery disease in end stage renal disease.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/21737022" id="rid17" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>18 : Association of serum phosphate levels with aortic valve sclerosis and annular calcification: the cardiovascular health study.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/16679093" id="rid18" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>19 : Relations of inflammation and novel risk factors to valvular calcification.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/27411840" id="rid19" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>20 : Association of inflammatory, lipid and mineral markers with cardiac calcification in older adults.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/17485576" id="rid20" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>21 : Association of fetuin-A with mitral annular calcification and aortic stenosis among persons with coronary heart disease: data from the Heart and Soul Study.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/15899935" id="rid21" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>22 : Associations of serum fetuin-A with malnutrition, inflammation, atherosclerosis and valvular calcification syndrome and outcome in peritoneal dialysis patients.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/17190241" id="rid22" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>23 : Massive calcification of the mitral valve annulus in an adolescent with Marfan syndrome. A case report.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/24777611" id="rid23" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>24 : Diagnosis and treatment of Marfan syndrome: an update.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/16046220" id="rid24" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>25 : Heart valve calcification in young patients with systemic lupus erythematosus: a window to premature atherosclerotic vascular morbidity and a risk factor for all-cause mortality.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/23388002" id="rid25" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>26 : Genetic associations with valvular calcification and aortic stenosis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/17359540" id="rid26" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>27 : Mitral annulus calcification is associated with valvular and cardiac structural abnormalities.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/15632881" id="rid27" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>28 : Epidemiology of mitral annular calcification and its predictive value for coronary events in African Americans: the Jackson Cohort of the Atherosclerotic Risk in Communities Study.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/6846165" id="rid28" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>29 : Prevalence of submitral (anular) calcium and its correlates in a general population-based sample (the Framingham Study).</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/16368289" id="rid29" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>30 : Clinical significance of calcification of the fibrous skeleton of the heart and aortosclerosis in community dwelling elderly. The Cardiovascular Health Study (CHS).</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/12654605" id="rid30" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>31 : Mitral annular calcification predicts cardiovascular morbidity and mortality: the Framingham Heart Study.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/21349485" id="rid31" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>32 : Relation of mitral annular calcium and coronary calcium (from the Multi-Ethnic Study of Atherosclerosis [MESA]).</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/21436252" id="rid32" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>33 : Mitral annular calcification predicts cardiovascular morbidity and mortality in middle-aged patients with atrial fibrillation: the Belgrade Atrial Fibrillation Study.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/19356491" id="rid33" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>34 : Impact of mitral annular calcification on cardiovascular events in a multiethnic community: the Northern Manhattan Study.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/12831818" id="rid34" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>35 : A prospective survey of patients with valvular heart disease in Europe: The Euro Heart Survey on Valvular Heart Disease.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/26936152" id="rid35" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>36 : Survival in Patients with Degenerative Mitral Stenosis: Results from a Large Retrospective Cohort Study.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/32553258" id="rid36" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>37 : The Natural History of Severe Calcific Mitral Stenosis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/15757600" id="rid37" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>38 : Prevalence of valve calcium and association of valve calcium with coronary artery disease, atherosclerotic vascular disease, and all-cause mortality in 137 patients undergoing hemodialysis for chronic renal failure.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/18840892" id="rid38" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>39 : Association of renal function with cardiac calcifications in older adults: the cardiovascular health study.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/17720520" id="rid39" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>40 : Kidney function and aortic valve and mitral annular calcification in the Multi-Ethnic Study of Atherosclerosis (MESA).</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/16382018" id="rid40" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>41 : Cross-sectional association of kidney function with valvular and annular calcification: the Framingham heart study.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/17052772" id="rid41" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>42 : Cardiac imaging in the evaluation of mitral annulus caseous calcification.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/21200011" id="rid42" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>43 : Multimodality cardiac imaging in the evaluation of mitral annular caseous calcification.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/888770" id="rid43" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>44 : Clinical manifestations of mitral annulus calcification, with emphasis on its echocardiographic features.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/7261279" id="rid44" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>45 : Functional mitral stenosis in patients with massive mitral annular calcification.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/27832900" id="rid45" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>46 : Severe Mitral Annular Calcification: Multimodality Imaging for Therapeutic Strategies and Interventions.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/18443031" id="rid46" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>47 : Association of mitral annular calcification and aortic valve morphology: a substudy of the aortic stenosis progression observation measuring effects of rosuvastatin (ASTRONOMER) study.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/27567138" id="rid47" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>48 : Mitral Annular Calcium and Mitral Stenosis Determined by Multidetector Computed Tomography in Patients Referred for Aortic Stenosis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/28039339" id="rid48" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>49 : Concomitant mitral annular calcification and severe aortic stenosis: prevalence, characteristics and outcome following transcatheter aortic valve replacement.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/12114097" id="rid49" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>50 : Mitral inflow and mitral annular motion velocities in patients with mitral annular calcification: evaluation by pulsed Doppler echocardiography and pulsed Doppler tissue imaging.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/7055055" id="rid50" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>51 : Echographic-quantified severity of mitral anulus calcification: prognostic correlation to related hemodynamic, valvular, rhythm, and conduction abnormalities.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/7055056" id="rid51" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>52 : High prevalence of symptomatic bradyarrhythmias due to atrioventricular node-fascicular and sinus node-atrial disease in patients with mitral anular calcification.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/6858870" id="rid52" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>53 : Conduction disturbances related to the site and severity of mitral anular calcification: a 2-dimensional echocardiographic and electrocardiographic correlative study.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/2916432" id="rid53" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>54 : Long-term follow-up of patients with echocardiographically detected mitral anular calcium and comparison with age- and sex-matched control subjects.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/15064104" id="rid54" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>55 : Mitral annular calcification is a predictor for incident atrial fibrillation.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/25341740" id="rid55" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>56 : Mitral annular calcification and incident atrial fibrillation in the Multi-Ethnic Study of Atherosclerosis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/28460029" id="rid56" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>57 : Mitral annular calcification progression and the risk of atrial fibrillation: results from MESA.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/11738305" id="rid57" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>58 : Association of mitral annulus calcification, aortic valve sclerosis and aortic root calcification with abnormal myocardial perfusion single photon emission tomography in subjects age&lt;or =65 years old.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/10719829" id="rid58" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>59 : Advanced mitral annular calcification is associated with severe coronary calcification on fast dual spiral computed tomography.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/12527666" id="rid59" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>60 : Mitral annular calcification: a marker of severe coronary artery disease in patients under 65 years old.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/9832091" id="rid60" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>61 : Mitral annular calcium detected by transthoracic echocardiography is a marker for high prevalence and severity of coronary artery disease in patients undergoing coronary angiography.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/18312759" id="rid61" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>62 : Comparison of prevalence of&gt;70% diameter narrowing of one or more major coronary arteries in patients with versus without mitral annular calcium and clinically suspected coronary artery disease.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/10998474" id="rid62" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>63 : Association between mitral annulus calcification and aortic atheroma: a prospective transesophageal echocardiographic study.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/11524077" id="rid63" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>64 : Association between mitral annular calcium and carotid artery stenosis and role of age and gender.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/15086260" id="rid64" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>65 : Bacterial endocarditis complicating mitral annular calcification: a clinical and echocardiographic study.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/28366636" id="rid65" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>66 : Mitral Annular Calcification as a Possible Nidus for Endocarditis: A Descriptive Series with Bacteriological Differences Noted.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/18095509" id="rid66" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>67 : Surgery for infective endocarditis on mitral annulus calcification.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/17967599" id="rid67" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>68 : Abscess in infective endocarditis: the value of transesophageal echocardiography and outcome: a 5-year study.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/11884249" id="rid68" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>69 : Differences and similarities between patients with and without end-stage renal disease, with regard to location of intracardiac calcification.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/23272892" id="rid69" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>70 : Cardiac computed tomography facilitates operative planning in patients with mitral calcification.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/15966936" id="rid70" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>71 : Caseous calcification of the mitral annulus: unusual case of spontaneous resolution.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/31403845" id="rid71" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>72 : Complexity of Defining Severe "Stenosis" From Mitral Annular Calcification.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/33332150" id="rid72" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>73 : 2020 ACC/AHA Guideline for the Management of Patients With Valvular Heart Disease: A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/33582068" id="rid73" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>74 : A Novel Assessment Using Projected Transmitral Gradient Improves Diagnostic Yield of Doppler Hemodynamics in Rheumatic and Calcific Mitral Stenosis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/19130998" id="rid74" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>75 : Echocardiographic assessment of valve stenosis: EAE/ASE recommendations for clinical practice.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/23743071" id="rid75" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>76 : Echocardiographic assessment of mitral stenosis: echocardiographic features of rheumatic mitral stenosis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/18620839" id="rid76" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>77 : Assessing mitral valve area and orifice geometry in calcific mitral stenosis: a new solution by real-time three-dimensional echocardiography.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/22922415" id="rid77" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>78 : Guidelines on the management of valvular heart disease (version 2012).</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/27037982" id="rid78" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>79 : Recommendations for the Evaluation of Left Ventricular Diastolic Function by Echocardiography: An Update from the American Society of Echocardiography and the European Association of Cardiovascular Imaging.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/28330654" id="rid79" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>80 : Doppler Echocardiography for the Estimation of LV Filling Pressure in Patients With Mitral Annular Calcification.</p>
</a>
</div>
</div>
</div>
</div>
</section>
</section>
<!-- End Main Menu Area -->
<!-- Start Search Popup Area -->
<!-- End Footer Area -->
<!-- Back to top -->
<a class="scrolltop" href="#top"><i class="icofont-hand-drawn-up"></i></a>
<!-- End Back to top -->
<!-- jQuery Min JS -->
<!-- Prpper JS -->
<!-- Bootstrap Min JS -->
<!-- Classy Nav Min Js -->
<!-- Owl Carousel Min Js -->
<!-- Magnific Popup JS -->
<!-- CounterUp JS -->
<!-- Waypoints JS -->
<!-- Form Validator Min JS -->
<!-- Contact Form Min JS -->
<!-- Main JS -->
<!-- Global site tag (gtag.js) - Google Analytics -->
</body>
</html>
